Aimmune Therapeutics (AIMT) “Hold” Rating Reaffirmed by Goldman Sachs; With $27 Target …

Gogo Inc (NASDAQ:GOGO) had a decrease of 1.61% in short interest. GOGO's SI was 34.18 million shares in October as released by FINRA. Its down …
Source: Google GoGo search